Final survival results from the PENELOPE-B trial investigating palbociclib versus placebo for patients with high-risk HR+/HER2− breast cancer and residual disease after neoadjuvant chemotherapy

S. Loibl, Miguel Martín, H. Bonnefoi, Michael Untch, Sung‐Han Kim, Harry D. Bear, José Á. García-Sáenz, M. Melé Olivé, Nicole Mc Carthy, Karen Gelmon, Catherine M. Kelly, S.-A. Im, Toralf Reimer, M. Martinez-Janez, Zhe Zhang, Masakazu Toi, Louise Provencher, H.S. Rugo, Michael Gnant, A. Makris, Alarcón Torres, Nader Hirmas, Johannes Holtschmidt, Valentina Nekljudova, Frederik Marmé